Inhibition effects of constituents of Radix Salviae Miltiorrhizae on proliferation and procollagen transcription of dermal fibroblasts in systemic sclerosis

National Medical Journal of China

Volumn 87, Issue 34, 2007, Pages 2426-2428

  Lü, Xiao Yan ^a   Li, Ming ^b   Weng, Meng Wu ^b  

^a SICHUAN UNIVERSITY   (China)

^b NONE

Author keywords

Fibroblasts; Scleroderma, systemic; Tanshinone

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; COLLAGEN; LITHOSPERMIC ACID; MESSENGER RNA; PROCOLLAGEN; PROCOLLAGEN TYPE 1; PROCOLLAGEN TYPE 3; PROTOCATECHUALDEHYDE; SALVIA MILTIORRHIZA EXTRACT; TANSHINONE; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COCULTURE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FIBROBLAST CULTURE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; PLASTIC SURGERY; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; SKIN FIBROBLAST; SYSTEMIC SCLEROSIS; TRANSCRIPTION REGULATION;

BENZALDEHYDES; CATECHOLS; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; COLLAGEN TYPE III; DRUGS, CHINESE HERBAL; FEMALE; FIBROBLASTS; HUMANS; LACTATES; MALE; PHENANTHRENES; PLANT EXTRACTS; PROCOLLAGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCLERODERMA, SYSTEMIC; TRANSCRIPTION, GENETIC;

EID: 37149013861     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Strehlow D, Korn JH. Biology of the scleroderma fibroblast. Curr Opin Rheumatol 1998, 10:572-578.
2. Chinese source.
3. Louneva N, Huaman G, Fertala J, et al. Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin. Arthritis Rheum, 2006, 54: 1298-1308.
4. Varga J. Antifibrotic therapy in scleroderma: extracellular or intracellular targeting of activated fibroblasts? Curr Rheumatol Rep, 2004, 6:164-170.
5. Chinese source.
6. Ohtsuka T, Koibuchi N, Sakai H, et al. Quantitative analysis of α1 (I) and α1 (III) procollagen mRNA expression in systemic sclerosis skin tissue - an in situ hybridization study. Arch Dermatol Res, 1999, 291:575-582.
7. Fleischmajer J, Dessau W, Timpl R, et al. Immunoflurescence analysis of collagen, fibronectin, and basement membrane protein in SSc skin. J Invest Dermatol, 1981, 75:270-274.
8. Jimenez SA, Feldman G, Bashey RI, et al. Co-ordinated increase in the expression of type I and type III exollagen genes in PSS fibroblasts. Biochem J, 1986, 237:837-843.
9. Ihn H. Scleroderma, fibroblasts, signaling, and excessive extracellular matrix. Curr Rheumatol Rep, 2005, 7:156-162.
10. Sandorfi N, Louneva N, Hitraya E, et al. Inhibition of collagen gene expression in systemic sclerosis dermal fibroblasts by mithramycin. Ann Rheum Dis, 2005 64:1685-1691.